Navigation Links
AEterna Zentaris: Lead Investigator for Cetrorelix Trials in BPH Wins Best Poster Presentation Award at European Association of Urology Meeting in Milan

lude frequent urination and/or urgent need to urinate, waking at night to urinate (nocturia), difficulty starting urination and/or weak urinary stream, and feeling that the bladder is not completely empty after urination. While current therapies provide some efficacy in BPH they are often associated with troublesome sexual side effects.

About AEterna Zentaris Inc.

AEterna Zentaris Inc. is a global biopharmaceutical company focused on endocrine therapy and oncology, with proven expertise in drug discovery, development and commercialization.
News releases and additional information are available at

Forward-Looking Statements

This press release contains forward-looking statements made pursuant to the safe harbor provisions of the U.S. Securities Litigation Reform Act of 1995. Forward-looking statements involve known and unknown risks and uncertainties, which could cause the Company's actual results to differ materially from those in the forward-looking statements. Such risks and uncertainties include, among others, the availability of funds and resources to pursue R&D projects, the successful and timely completion of clinical studies, the ability of the Company to take advantage of business opportunities in the pharmaceutical industry, uncertainties related to the regulatory process and general changes in economic conditions. Investors should consult the Company's quarterly and annual filings with the Canadian and U.S. securities commissions for additional information on risks and uncertainties relating to the forward-looking statements. Investors are cautioned not to rely on these forward-looking statements. The Company does not undertake to update these forward-looking statements. We disclaim any obligation to update any such factors or to publicly announce the result of any revisions to any of the forward-looking statements contained herein to reflect fut

Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. AEterna Zentaris Partner, Spectrum, Provides Update on Ozarelix in Benign Prostatic Hyperplasia
2. AEterna Zentaris Completes Patient Recruitment for First Phase 3 Efficacy Trial with Cetrorelix in Benign Prostatic Hyperplasia
3. AEterna Zentaris Announces Changes to its Management Team
4. AEterna Zentaris and Paladin Labs Complete Sale and Purchase of Miltefosine Rights
5. Aeterna Zentaris Begins Second Phase 3 Trial of Cetrorelix for Benign Prostatic Hyperplasia
6. Aeterna Zentaris Reports Fourth Quarter and Full-Year 2007 Financial and Operating Results
7. AEterna Zentaris and Paladin Labs Announce Sale and Purchase of Miltefosine Rights
8. AEterna Zentaris Announces the Departure of SVP, Administrative and Legal Affairs
9. Aeterna Zentaris to Announce Fourth Quarter and Full-Year 2007 Financial and Operating Results on March 5, 2008
10. AEterna Zentaris to Present at the Upcoming Roth Capital Partners 20th Annual OC Growth Stock Conference in Dana Point, California
11. AEterna Zentaris Reports First Patients Treated with Anti-Cancer Compound AEZS-108 in Phase 2 Trial in Ovarian and Endometrial Cancers
Post Your Comments:
(Date:10/8/2015)... , Oct. 8, 2015  Genetic testing for mutations ... the identification of more couples at risk of having ... presented today at the 2015 American Society of Human ... in Baltimore, Maryland . The study ... (NYSE: DGX ) are presenting at the conference ...
(Date:10/8/2015)... DURHAM, N.C. and WAYNE, Pa. ... leading management and technology consulting firm, has announced the ... Pennsylvania , majoring in a ... awarded over a two-year period. In addition, the selected ... industry through mentoring with Clarkston Consulting and participation in ...
(Date:10/8/2015)... 8, 2015 . ... --> Goldman Small Cap Research, a stock ... and microcap sectors, announced today that it has ... Biotech, Inc. (OTCQB - PMCB), a publicly traded, ... preparing treatments for cancer and diabetes. To view ...
(Date:10/8/2015)... RICHARDSON, Texas , Oct. 8, 2015 The 2015 ... graduate of The University of Texas at Dallas. Aziz ... from UT Dallas in 1977, is one ... detailing how cells continuously monitor and repair damaged DNA on a ... PhD in molecular and cell biology from UT Dallas ...
Breaking Biology Technology:
... new study shows that the availability of hydrogen plays ... makeup of graphene oxide, a material that has potential ... and energy storage. The study also found ... chemical properties continue to evolve for more than a ...
... Hill Community College (BHCC) celebrated the graduation of ... (CBCP) in a ceremony that also marked the ... collaborative effort between BHCC,s Workforce Development Center, the ... targets low-income Cambridge residents who complete – at ...
... Technologies (DTT) is pleased to announce the first sale ... Pediatric Dental Group PC.   "We,re excited to add ditto ... it in our office and had spectacular results," states ... ditto™ dental is a clinical tool developed ...
Cached Biology Technology:
(Date:9/10/2015)... 2015 Report Details The global ... upon previous expectations of revenues, consumer adoption and even ... in which wearables begin to achieve that mass market ... main reasons is the entrance of Apple to the ... market, but the overall size of the wearable technology ...
(Date:9/9/2015)... , Sept. 9, 2015  NuData Security announced ... solution-based milestones, furthering the company,s commitment to protecting ... fraud. NuData Security,s online fraud detection ... company,s growth cycle. The product combines continual analysis ... good user behavior from fraudulent behavior, allowing the ...
(Date:9/2/2015)... -- About hand geometry biometrics Security has been ... and hospitals as well as for individuals to secure ... are used to prevent unauthorised access. Hand geometry biometrics ... an individual, width of the fingers, and thickness of ... reflectors can be used for capturing the image. Since ...
Breaking Biology News(10 mins):
... January 14, 2013 Using an innovative approach, scientists ... structure of Ltn1, a recently discovered "quality-control" protein that ... and animals. Ltn1 appears to be essential ... also be relevant to human neurodegenerative diseases, for an ...
... 2013Taking a vitamin D supplement and drinking cow,s milk are ... D is in a child,s body, new research has found. ... colour and exposure to the sun, according to Dr. Jonathon ... "Early childhood is a critical stage in human development, so ...
... is Everywhere" tenet of bacterial distribution in the ocean, ... "bipolar" species of bacteria that occur in the Arctic ... they found even fewer bipolar species than would turn ... everywhere. "That suggests that there are forces that are ...
Cached Biology News: